Co-Diagnostics, Inc. (CODX) › Capital ExpendituresCo-Diagnostics, Inc. (CODX) — Capital ExpendituresAnnual figures by period end, from SEC filings.2016-12-31: $12.2K2017-12-31: $129.3K2018-12-31: $41.3K2019-12-31: $113.2K2020-12-31: $774.4K2021-12-31: $669.5K2022-12-31: $1.43M2023-12-31: $1.37M2024-12-31: $748.4K2025-12-31: $700.0K$700.0K2016-12-31Capital Expenditures (USD)2025-12-31Period endedCapital ExpendituresChange YoYSource filing2025-12-31$700.0K-6.5%2026-03-31From 2025-01-012024-12-31$748.4K-45.2%2026-03-31From 2024-01-012023-12-31$1.37M-4.4%2025-03-27From 2023-01-012022-12-31$1.43M+113.2%2024-03-14From 2022-01-012021-12-31$669.5K-13.6%2023-03-16From 2021-01-012020-12-31$774.4K+583.8%2022-03-24From 2020-01-012019-12-31$113.2K+174.0%2021-03-25From 2019-01-012018-12-31$41.3K-68.0%2020-03-30From 2018-01-012017-12-31$129.3K+956.3%2019-04-01From 2017-01-012016-12-31$12.2K—2018-03-28From 2016-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)